If you are preparing for CSIR NET 2026, there is one topic that has consistently appeared across previous years and is expected to dominate the Life Sciences paper again — CRISPR-Cas9 mechanism and applications for CSIR NET 2026. Understanding this topic deeply is not optional anymore. It is a scoring powerhouse. Whether you are targeting Part B or Part C, questions from genome editing, molecular tools, and biotechnology applications consistently pull from this one concept.
This guide has been written specifically for CSIR NET aspirants who want conceptual clarity, exam-relevant depth, and real application knowledge — all in one place. Read it from beginning to end, bookmark it, and return to it as you revise. By the time you are done, CRISPR will not feel like a difficult chapter. It will feel like your strongest one.
What Is CRISPR-Cas9? Understanding the Origin Before the Mechanism
Before jumping into how CRISPR-Cas9 works, you need to know where it comes from — because that origin story also helps you remember the logic of the system.
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. These are naturally occurring sequences found in the genomes of bacteria and archaea. They are part of the prokaryotic immune system. When a bacterium survives a viral attack, it stores a small piece of the viral DNA between its own chromosomal repeats — in these CRISPR arrays. If the same virus attacks again, the bacterium uses that stored memory to recognise and destroy the viral genetic material.
The Cas9 protein (CRISPR-associated protein 9) is the molecular scissor in this system. It is a nuclease — an enzyme that cuts DNA. Together, CRISPR and Cas9 form a revolutionary gene editing system that scientists have adapted to edit virtually any genome on the planet.
The scientists who first recognised the potential of this system and developed it into a programmable tool were Jennifer Doudna and Emmanuelle Charpentier, who were awarded the Nobel Prize in Chemistry in 2020 for this work.
The Step-by-Step Mechanism of CRISPR-Cas9 — Exam-Level Detail
This is the core of CRISPR-Cas9 mechanism and applications for CSIR NET 2026, and this is where most marks are won or lost. Learn this sequence carefully.
Step 1 — Designing the Guide RNA (gRNA)
The system works because of a small RNA molecule called the guide RNA (gRNA) or, more precisely, the single guide RNA (sgRNA). In the natural system, there are two RNA components — the crRNA (CRISPR RNA) and tracrRNA (trans-activating crRNA). In the laboratory-adapted version, these two are fused into a single guide RNA for simplicity.
The gRNA is around 20 nucleotides long at its target-specific region. This sequence is designed by the researcher to be complementary to the DNA sequence they wish to edit. This is the programmable component — change the 20-nt sequence of the gRNA, and you change which part of the genome Cas9 will cut. This simplicity is precisely why CRISPR revolutionised science.
Step 2 — Formation of the CRISPR-Cas9 Ribonucleoprotein Complex
The sgRNA binds to the Cas9 protein to form a ribonucleoprotein (RNP) complex. Cas9 then undergoes a conformational change — it goes from a relaxed, inactive form to an active, DNA-scanning form. The complex is now ready to search the genome.
Step 3 — Target Recognition and the PAM Sequence
Cas9 does not scan the entire genome randomly. It first looks for a short DNA motif called the PAM (Protospacer Adjacent Motif) sequence. For the most commonly used Cas9 from Streptococcus pyogenes (SpCas9), the PAM sequence is 5′-NGG-3′ (where N is any nucleotide). This PAM must be located immediately downstream (3′ side) of the target sequence on the non-template strand.
Once Cas9 finds a PAM sequence, it unwinds the double-stranded DNA locally and checks whether the adjacent sequence matches the gRNA. If complementarity is confirmed across all 20 nucleotides (or close to it), the complex locks in.
Step 4 — DNA Cleavage
Upon target verification, Cas9 cleaves the DNA using its two nuclease domains:
- RuvC domain — cleaves the non-template strand (the strand NOT complementary to the gRNA)
- HNH domain — cleaves the template strand (the strand complementary to the gRNA)
Both domains act together to produce a blunt-ended double-strand break (DSB) approximately 3 base pairs upstream of the PAM sequence. This is a precise, localised cut — not a random nick.
Step 5 — DNA Repair Pathways (This Is Where Editing Happens)
The cell detects the double-strand break and activates its repair machinery. There are two major pathways:
1. Non-Homologous End Joining (NHEJ) This is the default, error-prone pathway. The cell ligates the broken ends back together, but frequently introduces small insertions or deletions — called indels. These indels often shift the reading frame of a gene, resulting in a loss of function (knockout). NHEJ is used when the goal is to disrupt a gene.
2. Homology-Directed Repair (HDR) If a DNA template with homologous sequences flanking the cut site is provided alongside the Cas9-gRNA complex, the cell can use it as a template for precise repair. This allows insertion of a specific sequence, correction of a point mutation, or any desired modification. HDR is used for precision editing but is less efficient than NHEJ and primarily occurs in dividing cells.
V
visualize
Key Molecular Components — Quick Revision Table
For fast revision before the CSIR NET 2026 exam, memorise these components and their functions:
| Component | Type | Function |
|---|---|---|
| Cas9 | Protein (nuclease) | Creates DSB in target DNA |
| sgRNA | RNA (≈100 nt total) | Guides Cas9 to target |
| crRNA | RNA (20 nt) | Target-specific recognition |
| tracrRNA | RNA (scaffold) | Anchors crRNA to Cas9 |
| PAM (5′-NGG-3′) | DNA sequence | Required for Cas9 binding |
| RuvC domain | Nuclease domain | Cuts non-template strand |
| HNH domain | Nuclease domain | Cuts template strand |
Applications of CRISPR-Cas9 — The Part CSIR NET Questions Love
The applications section is where the exam tests your breadth of knowledge. The CRISPR-Cas9 mechanism and applications for CSIR NET 2026 syllabus covers applications across medicine, agriculture, research, and diagnostics. Know all of them.
1. Gene Therapy and Human Disease Treatment
CRISPR-Cas9 has opened the door to treating genetic diseases at the DNA level rather than merely managing symptoms. The most celebrated application to date is in sickle cell disease and beta-thalassemia. The FDA approved the first CRISPR-based therapy, Casgevy (exagamglogene autotemcel), in late 2023 — a landmark moment in medicine. The therapy reactivates fetal haemoglobin production by targeting the BCL11A enhancer, effectively compensating for the mutated adult haemoglobin gene.
Other diseases being actively targeted include:
- Duchenne Muscular Dystrophy (DMD) — exon skipping to restore dystrophin reading frame
- Transthyretin amyloidosis — liver-targeted CRISPR therapy to reduce misfolded protein production
- Leber Congenital Amaurosis (LCA10) — first in vivo CRISPR therapy directly injected into the eye
- HIV — targeting the integrated proviral DNA in host cells
2. Cancer Immunotherapy
CRISPR is transforming cancer treatment by engineering CAR-T cells — chimeric antigen receptor T cells — with far greater precision. Researchers knock out genes like PD-1 (a checkpoint inhibitor) and TRAC (T cell receptor alpha chain) to create T cells that are more potent, longer-lasting, and less likely to attack healthy tissue. Early clinical trials from the University of Pennsylvania showed encouraging results using multiplexed CRISPR editing in cancer patients.
3. Agricultural Biotechnology
CRISPR-Cas9 has fundamentally changed crop improvement. Unlike traditional GMOs where foreign genes are inserted, CRISPR can be used to make precise knockouts or modifications that often produce results indistinguishable from natural mutation — and therefore bypass certain GMO regulations in some countries.
Key agricultural applications include:
- Disease resistance — editing the MLO gene in wheat to confer powdery mildew resistance
- Drought tolerance — modifying stomatal regulation genes in maize and rice
- Yield improvement — editing the GW5 and GS3 genes in rice to increase grain size
- Reduced allergenicity — reducing gluten proteins in wheat for celiac disease patients
- Hornless cattle — targeting the POLLED gene in dairy cattle, eliminating the need for painful dehorning
4. Infectious Disease Diagnostics — SHERLOCK and DETECTR
Two CRISPR-based diagnostic platforms have emerged as highly sensitive molecular diagnostic tools:
- SHERLOCK (Specific High Sensitivity Reporter Unlocking) — developed at the Broad Institute, uses Cas13 (which cleaves RNA) for detection of nucleic acid targets including SARS-CoV-2, dengue, and Zika virus
- DETECTR (DNA Endonuclease Targeted CRISPR Trans Reporter) — uses Cas12a and was used for rapid COVID-19 testing
These are important for CSIR NET because they demonstrate CRISPR beyond gene editing — into diagnostics.
5. Functional Genomics and Basic Research
At the fundamental research level, CRISPR has become the gold standard for:
- Genome-wide screens — CRISPR libraries containing gRNAs for every gene in a genome are used to identify genes involved in drug resistance, cancer progression, or viral entry
- CRISPRi (interference) — using a catalytically dead Cas9 (dCas9) fused to a transcriptional repressor (KRAB domain) to silence gene expression without cutting DNA
- CRISPRa (activation) — dCas9 fused to transcriptional activators (VP64, p65, Rta) to upregulate gene expression
- Base editing — dCas9 fused to a deaminase enzyme converts one DNA base to another (C→T or A→G) without creating a DSB
- Prime editing — a more recent advancement using a reverse transcriptase-Cas9 fusion to write new genetic information directly into a genomic site
6. Epigenome Editing
Beyond the DNA sequence itself, dCas9 has been fused with epigenetic modifiers — such as DNA methyltransferases, histone acetyltransferases, and histone deacetylases — to precisely modify epigenetic marks at specific loci. This opens the door to treating diseases caused by epigenetic dysregulation without permanently altering the DNA sequence.
Limitations and Challenges of CRISPR-Cas9 — Critical for Part C
CSIR NET Part C requires analytical thinking, and questions often ask about limitations or compare technologies. Know these:
Off-target effects — The most significant concern. Cas9 can bind and cut at genomic locations with partial complementarity to the gRNA. This is particularly dangerous in therapeutic applications. Solutions include high-fidelity Cas9 variants (eSpCas9, HiFi Cas9), truncated gRNAs, and paired nickase approaches.
Delivery challenges — Getting CRISPR components into cells, tissues, or whole organisms is technically demanding. Current delivery systems include viral vectors (AAV, lentivirus), lipid nanoparticles (LNPs), ribonucleoprotein (RNP) electroporation, and microinjection. Each has limitations in terms of cargo size, immune response, and tissue specificity.
Low HDR efficiency — Homology-directed repair, which enables precision editing, occurs mainly in S and G2 phases of the cell cycle and is far less efficient than NHEJ. It is especially low in post-mitotic cells (neurons, muscle cells), limiting therapeutic applications.
Immunogenicity — Cas9 is a bacterial protein. Human immune systems may recognise it as foreign, which raises concerns for in vivo therapeutic delivery. Studies have found pre-existing immunity to SpCas9 and SaCas9 in a significant fraction of the human population.
PAM requirement — The necessity of an NGG PAM sequence limits which genomic sites can be targeted. Researchers have developed PAM-relaxed Cas9 variants (xCas9, SpCas9-NG) to address this.
Ethical concerns — The germline editing controversy sparked by the He Jiankui case (2018, CCR5 editing in human embryos) raised profound ethical questions that have led to international moratoria on heritable human genome editing.
CRISPR Variants You Must Know for CSIR NET 2026
The exam is increasingly testing knowledge of next-generation CRISPR tools:
| Tool | Cas protein | Key feature | Application |
|---|---|---|---|
| Base editing | dCas9 + deaminase | Single base conversion (no DSB) | Point mutation correction |
| Prime editing | Cas9-RT fusion | Write any edit without DSB or donor | Precision correction |
| CRISPRi | dCas9 + KRAB | Gene silencing | Functional genomics |
| CRISPRa | dCas9 + VP64 | Gene activation | Functional genomics |
| Cas12a (Cpf1) | Cpf1 | Staggered cuts, AT-rich PAM | Diagnostics (DETECTR) |
| Cas13 | Cas13a/b | Targets RNA, not DNA | RNA knockdown, diagnostics |
| Epigenome editors | dCas9 + modifier | Epigenetic mark installation | Disease modeling |
CRISPR-Cas9 Compared to Older Gene Editing Tools
CSIR NET frequently asks comparative questions. Here is a rapid comparison:
ZFNs (Zinc Finger Nucleases) — First-generation tools. Protein engineering required for each new target. Expensive, time-consuming, off-target toxicity. Used Fok1 nuclease.
TALENs (Transcription Activator-Like Effector Nucleases) — Second generation. Easier to design than ZFNs. Still protein-based. Also use Fok1. More specific but less efficient than CRISPR.
CRISPR-Cas9 — Third generation. RNA-guided (easily programmable), low cost, high efficiency, multiplexing possible (editing multiple genes simultaneously with multiple gRNAs), adaptable to virtually any organism. Clear winner for most applications.
How to Prepare This Topic for CSIR NET 2026 with Chandu Biology Classes
For students serious about cracking CRISPR-Cas9 mechanism and applications for CSIR NET 2026 and the broader Life Sciences paper, structured coaching makes an enormous difference — especially for Part C where application-level thinking is tested.
Chandu Biology Classes is one of the most trusted names for CSIR NET Life Sciences preparation. The faculty explains complex molecular biology topics like CRISPR with conceptual depth and exam-relevant framing, ensuring students don’t just memorise but truly understand — and can apply knowledge to novel problems in the exam.
Fee Structure at Chandu Biology Classes:
- Online Coaching — ₹25,000
- Offline Coaching — ₹30,000
For students outside the city or those who prefer flexibility, the online program delivers the same quality of instruction. Both modes are comprehensive, covering the full CSIR NET Life Sciences syllabus including molecular biology, genetics, cell biology, biochemistry, ecology, and evolution.
If your goal is to rank in the top percentile of CRISPR-Cas9 mechanism and applications for CSIR NET 2026 and all other topics, joining a dedicated coaching program like Chandu Biology Classes can be a decisive advantage. The structured schedule, regular mock tests, and personalised guidance help you move from knowing the basics to confidently answering Part C questions under exam pressure.
Previous Year Question Pattern — CRISPR in CSIR NET
While exact questions are not reproducible here, CRISPR-related questions in CSIR NET Life Sciences papers have appeared in these formats:
- Mechanism-based MCQs — “Which domain of Cas9 cleaves the non-template strand?” → RuvC
- Application questions — “Which CRISPR tool can be used to activate a silenced gene without altering DNA sequence?” → CRISPRa
- Comparison questions — “What is the key advantage of base editing over conventional CRISPR-Cas9?” → No DSB, greater precision
- Diagram-based questions — Identifying steps in CRISPR mechanism from a schematic
- Recent developments — Questions on SHERLOCK, prime editing, and clinical approvals
Part C questions often present a research scenario and ask students to identify the most appropriate CRISPR tool to use, or to predict the outcome of a specific editing strategy.
FAQ — Trending Questions Students Are Searching for CSIR NET 2026
Q1. What is the full form and origin of CRISPR? CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. It originates from the natural adaptive immune system of bacteria and archaea, where short viral DNA sequences are stored between repetitive genomic sequences to provide immunological memory against repeat viral infections.
Q2. Which domains of Cas9 are responsible for DNA cleavage? Cas9 has two nuclease domains — the RuvC domain cleaves the non-template strand and the HNH domain cleaves the template strand. Both act simultaneously to produce a blunt-ended double-strand break three base pairs upstream of the PAM sequence.
Q3. What is the PAM sequence and why is it important? The PAM (Protospacer Adjacent Motif) is a short DNA sequence (5′-NGG-3′ for SpCas9) located adjacent to the target sequence. It is required for Cas9 binding and DNA unwinding. Without a PAM, Cas9 will not cleave the DNA even if the gRNA is complementary to the target sequence.
Q4. What is the difference between NHEJ and HDR in the context of CRISPR editing? NHEJ (Non-Homologous End Joining) is an error-prone repair pathway that introduces indels at the cut site, causing frameshift mutations and gene knockouts. HDR (Homology-Directed Repair) uses a provided DNA template to introduce precise edits such as gene corrections or insertions. NHEJ is more efficient but imprecise; HDR is precise but less efficient, especially in non-dividing cells.
Q5. What is dCas9 and what is it used for? dCas9 (dead Cas9) is a catalytically inactive form of Cas9 where both the RuvC and HNH domains carry inactivating mutations (D10A and H840A). It retains DNA binding ability guided by the sgRNA but does not cut. It is used as a programmable DNA-binding scaffold for CRISPRi (gene silencing), CRISPRa (gene activation), base editing, prime editing, and epigenome editing.
Q6. What is base editing and how does it differ from conventional CRISPR-Cas9? Base editing uses a dCas9 or nickase Cas9 (nCas9) fused to a deaminase enzyme. It converts one DNA base to another (e.g., cytosine to uracil, which is then repaired as thymine → C→T edit; or adenine to inosine → A→G edit) without creating a double-strand break and without requiring an HDR template. It is more precise and produces fewer unintended indels compared to conventional CRISPR cutting.
Q7. What is prime editing and why is it considered an advance over base editing? Prime editing uses a fusion of Cas9 nickase with a reverse transcriptase (RT), along with a pegRNA (prime editing guide RNA) that encodes both the target site and the desired edit. It can install any type of point mutation, small insertions, or small deletions without DSBs or HDR templates. It is more versatile than base editing (which is limited to transition mutations) and safer because it avoids DSBs.
Q8. What are the major challenges of using CRISPR-Cas9 in clinical therapy? Major challenges include off-target editing at genomic sites with partial gRNA complementarity, inefficient delivery of CRISPR components into target tissues (especially post-mitotic cells), low efficiency of HDR in non-dividing cells, pre-existing immune responses against bacterial Cas9 proteins, and ethical concerns about germline editing.
Q9. What is SHERLOCK and how is it used in diagnostics? SHERLOCK (Specific High Sensitivity Reporter Unlocking) is a CRISPR-based diagnostic platform that uses Cas13 — which cleaves RNA with collateral activity. When Cas13 binds its target RNA, it non-specifically cleaves nearby reporter RNA molecules, releasing a fluorescent signal. SHERLOCK can detect specific nucleic acid sequences (viral RNA, pathogen DNA) with attomolar sensitivity and has been used for detecting SARS-CoV-2, dengue, and Zika.
Q10. How many times has CRISPR appeared in CSIR NET Life Sciences papers and which sections? CRISPR-related questions have appeared multiple times in Part B and Part C of CSIR NET Life Sciences, particularly under the Molecular Biology, Biotechnology, and Cell Biology sections. The frequency has increased over the past four years, and with the 2026 exam approaching, topics like base editing, prime editing, and clinical applications are particularly likely to be tested.
Q11. Is CRISPR-Cas9 the same as genetic engineering? CRISPR-Cas9 is a form of genetic engineering — specifically, a precision genome editing tool. However, unlike older recombinant DNA approaches that involve inserting foreign DNA, CRISPR can also be used to make targeted edits, knockouts, or regulations without inserting any foreign sequences. It is far more precise, affordable, and versatile than earlier genetic engineering tools.
Q12. What is the significance of the Nobel Prize awarded for CRISPR? Jennifer Doudna and Emmanuelle Charpentier received the Nobel Prize in Chemistry 2020 for developing CRISPR-Cas9 as a programmable genome editing tool. Their 2012 paper in Science demonstrated that a simplified two-component system (Cas9 + sgRNA) could be programmed to cleave specific DNA sequences in a test tube, laying the foundation for its use in all living systems.
Final Revision Checklist — CRISPR-Cas9 for CSIR NET 2026
Before the exam, make sure you can confidently answer each of these without hesitation:
- Full mechanism from gRNA design to DNA repair pathway
- Names and functions of all molecular components
- PAM sequence for SpCas9 (NGG) and SaCas9 (NNGRRT)
- Differences between NHEJ and HDR outcomes
- Five or more disease applications with specific examples
- Differences between ZFNs, TALENs, and CRISPR-Cas9
- Functions of dCas9, CRISPRi, CRISPRa, base editing, prime editing
- Cas12a and Cas13 and their diagnostic applications
- Off-target effect mechanisms and how they are minimised
- Ethical concerns, especially regarding germline editing
Conclusion
Mastering CRISPR-Cas9 mechanism and applications for CSIR NET 2026 is not just about passing an exam. It is about understanding one of the most important scientific tools of the 21st century. From single base corrections in a human patient to drought-resistant crops to ultra-sensitive viral diagnostics — CRISPR’s reach is as wide as biology itself.
Build your conceptual foundation with this guide, revise the molecular details rigorously, and use exam-focused coaching from trusted sources like Chandu Biology Classes — available at ₹25,000 online or ₹30,000 offline — to sharpen your edge. The CSIR NET 2026 exam will reward students who understand, not just remember.
Start today. The preparation that begins now is what determines your rank later.